(19)
(11) EP 4 604 936 A1

(12)

(43) Date of publication:
27.08.2025 Bulletin 2025/35

(21) Application number: 23805665.9

(22) Date of filing: 19.10.2023
(51) International Patent Classification (IPC): 
A61K 31/05(2006.01)
A61P 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/1617; A61K 9/1652; A61K 31/05; A61P 9/00; A61K 31/685; A23L 33/105; A23L 29/212
 
C-Sets:
  1. A61K 31/685, A61K 2300/00;
  2. A61K 31/05, A61K 2300/00;

(86) International application number:
PCT/IB2023/060563
(87) International publication number:
WO 2024/084428 (25.04.2024 Gazette 2024/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 21.10.2022 IT 202200021711

(71) Applicant: Neilos S.r.l.
80063 Piano di Sorrento (NA) (IT)

(72) Inventor:
  • DI MAIO, Umberto
    80063 Piano di Sorrento NA (IT)

(74) Representative: Di Giovine, Paolo et al
Società Italiana Brevetti S.p.A. Piazza di Pietra, 38-39
00186 Roma
00186 Roma (IT)

   


(54) NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION COMPRISING RESVERATROL